Trial intelligence / Profile preview

Sirolimus vs Standard Treatment in Pediatric Kidney Transplant Patients

NCT00005113Phase 3Terminated

Sponsor
Boston Children's Hospital
Start
Jul 1999
Primary completion
Jul 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sirolimus in kidney transplant rejection, sponsored by Boston Children's Hospital. Started Jul 1999; status: terminated.

02

Drugs

sirolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00005113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call